The hippo signaling pathway effector YES-associated protein (YAP) has been found to promote resistance to MEK and RAF inhibition in non-small cell lung cancer [11], while TNKS activity protected lung cancer cells from Epidermal Growth Factor Receptor (EGFR) inhibition [12]. Here, EGFR is linked to non-small cell lung carcinoma.